ounded in 1959, Fluid Metering Inc. (FMI), is internationally recognized as the global leader in life science pumps and dispensers, pioneering the first patented valveless rotating and reciprocating piston metering pump concept. It is a remarkable growth success story and one developed with the guidance of Roper Technologies, a diversified technology company which acquired Fluid Metering in 2017. Since joining FMI in 2018, Robert Morin, Vice President of Commercial Operations has built upon its growth strategy which has seen the company accelerate its journey towards strengthened quality and compliance, enhanced operating efficiencies, and most especially launching new, innovative product programs.
FMI’s Growth Strategy
The ultimate aim at Fluid Metering is to meet the emerging needs of the medical device and life sciences product manufacturers with custom precision fluid dispensing solutions. To accomplish this mission FMI will respond to shifting secular trends in a post COVID environment by adapting go to market strategies to meet customer specific application requirements
To implement the strategic vision of providing new and longtime legacy customers with superior valued added services, the Fluid Metering team is committed to execute a three-pronged approach focusing on the company’s organizational key strengths and core competencies.
Enable industry leading personalized customer service and support via integrated solutions with a high human touch from initial inquiry to post installation support. Alongside facilitating a restructured consultative sales strategy capable of helping solve prospects and customer business problems that build long term relationships beyond the initial sale.
Enhance virtual communications designed to effectively market FMI products/services through a variety of channels by creating valuable relevant content to attract and acquire a clearly defined audience.
Empower new product development concepts to gain competitive advantage by designing advanced microfluidic technology solutions that meet a high level of compliance and quality assurance standards for optimal functionality and market appeal.
Progress To Date In 2020, Fluid Metering completed a rebranding initiative that introduced a new logo on a redesigned website powered by HubSpot CRM to help streamline business processes, accelerate lead generation, and build brand loyalty while providing top-quality service to increase customer satisfaction.
www.fluidmetering.com
Concurrently, that same year, Fluid Metering welcomed Sean Madden to lead the team of product engineers committed to developing innovative custom microfluidic solutions to enhance the company’s portfolio and drive market differentiation to accelerate growth opportunities. Since then, the FMI product development team has been working diligently to expand and develop project ideas creating next generation technologies that satisfy market specific needs.
Most notably, in January 2021, Fluid Metering announced the launch of the FVD Variable Dispense Pump (patent pending). The low-profile design and function of the FVD addresses challenging requirements from the life sciences sector in need of a simplified fluidic architecture. The FVD Variable Dispense enables on the fly mixing for high precision mix ratios and allows flushing and priming all within a smaller footprint. At the core of the system is the patented CeramPump® design featuring a valveless piston liner set for precise fluid control capabilities. Equally important, is that the pump will maintain drift-free performance long-term, thus eliminating the need for recalibration, maintenance downtime and costly service calls.
In Conclusion
Fluid Metering is committed to building a world class portfolio of metering and dispensing technologies designed to meet specific life sciences application requirements with accuracy, precision, and reliability. Looking out over the months and years ahead, the Fluid Metering Team are preparing to launch several new technically advanced microfluidic solutions, make significant life cycle improvements to existing offerings and expand market penetration into new OEM and Life Sciences Industry.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170
